Literature DB >> 21984228

The adenoma hunt in colorectal cancer screening: defining the target.

Anke H Sillars-Hardebol1, Beatriz Carvalho, Manon van Engeland, Remond J A Fijneman, Gerrit A Meijer.   

Abstract

Colorectal adenomas are precursor lesions of colorectal cancer. Different biological and metabolic processes contribute to adenomagenesis. Subsequent progression to carcinoma occurs in only about 5% of the cases. Detection and removal of all adenomas would reduce CRC incidence and mortality, but at the cost of major over-treatment. Classical morphological characteristics fail to accurately discriminate between adenomas that will become malignant and those that will not. Understanding the biology of cancer development will help to better characterize adenomas at high risk of progression, and subsequently establish triage tests that allow to safely reserve colonoscopy only for individuals at high probability of having truly high-risk colorectal adenomas. Screening tests based on genomic changes that affect relevant biological and metabolic processes hold most promise in this respect.
Copyright © 2011 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21984228     DOI: 10.1002/path.3012

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  19 in total

1.  Cost-effectiveness of High-performance Biomarker Tests vs Fecal Immunochemical Test for Noninvasive Colorectal Cancer Screening.

Authors:  Iris Lansdorp-Vogelaar; S Lucas Goede; Linda J W Bosch; Veerle Melotte; Beatriz Carvalho; Manon van Engeland; Gerrit A Meijer; Harry J de Koning; Marjolein van Ballegooijen
Journal:  Clin Gastroenterol Hepatol       Date:  2017-07-18       Impact factor: 11.382

2.  Sorbitol dehydrogenase overexpression and other aspects of dysregulated protein expression in human precancerous colorectal neoplasms: a quantitative proteomics study.

Authors:  Anuli Uzozie; Paolo Nanni; Teresa Staiano; Jonas Grossmann; Simon Barkow-Oesterreicher; Jerry W Shay; Amit Tiwari; Federico Buffoli; Endre Laczko; Giancarlo Marra
Journal:  Mol Cell Proteomics       Date:  2014-02-24       Impact factor: 5.911

3.  The Foundation in Evidence of Medical and Dental Telephone Consultations.

Authors:  Martina Albrecht; Florian Isenbeck; Jüürgen Kasper; Ingrid Mühlhauser; Anke Steckelberg
Journal:  Dtsch Arztebl Int       Date:  2016-06-06       Impact factor: 5.594

4.  SAGES TAVAC safety and efficacy analysis confocal laser endomicroscopy.

Authors:  Mazen R Al-Mansour; Antonio Caycedo-Marulanda; Brian R Davis; Abdulrahim Alawashez; Salvatore Docimo; Alia Qureshi; Shawn Tsuda
Journal:  Surg Endosc       Date:  2020-05-13       Impact factor: 4.584

5.  A healthy lifestyle index is associated with reduced risk of colorectal adenomatous polyps among non-users of non-steroidal anti-inflammatory drugs.

Authors:  Fred K Tabung; Susan E Steck; James B Burch; Chin-Fu Chen; Hongmei Zhang; Thomas G Hurley; Philip Cavicchia; Melannie Alexander; Nitin Shivappa; Kim E Creek; Stephen C Lloyd; James R Hebert
Journal:  J Prim Prev       Date:  2015-02

6.  CSE1L, DIDO1 and RBM39 in colorectal adenoma to carcinoma progression.

Authors:  Anke H Sillars-Hardebol; Beatriz Carvalho; Jeroen A M Beliën; Meike de Wit; Pien M Delis-van Diemen; Marianne Tijssen; Mark A van de Wiel; Fredrik Pontén; Gerrit A Meijer; Remond J A Fijneman
Journal:  Cell Oncol (Dordr)       Date:  2012-06-19       Impact factor: 6.730

Review 7.  Early detection: the impact of genomics.

Authors:  M C J van Lanschot; L J W Bosch; M de Wit; B Carvalho; G A Meijer
Journal:  Virchows Arch       Date:  2017-06-01       Impact factor: 4.064

8.  Paleolithic and Mediterranean diet pattern scores and risk of incident, sporadic colorectal adenomas.

Authors:  Kristine A Whalen; Marji McCullough; W Dana Flanders; Terryl J Hartman; Suzanne Judd; Roberd M Bostick
Journal:  Am J Epidemiol       Date:  2014-10-17       Impact factor: 4.897

9.  Relationship between tumor and peripheral blood NPRL2 mRNA levels in patients with colorectal adenoma and colorectal cancer.

Authors:  Ai-yun Liu; Dian-Ggang Liu; Ya-ju Du; Feng-hua Pei; Guang Yang; Bing-rong Liu; Hui-tao Zhang; Xin-hong Wang; Yu-jing Fan; Ying-zhun Chen; Yang Jiang; Jing Chen
Journal:  Cancer Biol Ther       Date:  2014-02-12       Impact factor: 4.742

Review 10.  Interval cancers after colonoscopy-insights and recommendations.

Authors:  Silvia Sanduleanu; Ad M Masclee; Gerrit A Meijer
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-08-21       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.